Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2017 2
2019 1
2022 2
2023 2
2024 2
2025 2
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for M. karamlou
Your search for M. Karimlou retrieved no results
Methylprednisolone for Infant Heart Surgery: Subpopulation Analyses of a Randomized Controlled Trial.
Sunthankar SD, Hill KD, Jacobs JP, Baldwin HS, Jacobs ML, Li JS, Graham EM, Blasiole B, Husain SA, Bleiweis MS, Mettler B, Benscoter A, Wald E, Karamlou T, Van Bergen AH, Eghtesady P, Scott JP, Anderson BR, Alfieris G, Vener DF, Kannankeril PJ. Sunthankar SD, et al. Crit Care Med. 2025 Jul 1;53(7):e1470-e1480. doi: 10.1097/CCM.0000000000006721. Epub 2025 May 21. Crit Care Med. 2025. PMID: 40396812 Free PMC article. Clinical Trial.
Human fitting of pediatric and infant continuous-flow total artificial heart: visual and virtual assessment.
Miyagi C, Ahmad M, Karimov JH, Polakowski AR, Karamlou T, Yaman M, Fukamachi K, Najm HK. Miyagi C, et al. Front Cardiovasc Med. 2023 Jul 17;10:1193800. doi: 10.3389/fcvm.2023.1193800. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37529709 Free PMC article.
The cutoff values were: BW: 5.71 kg, Ht: 59.0 cm, BSA: 0.31 m(2). These cutoff values were additionally confirmed to be optimal by CT imaging. CONCLUSIONS: This study demonstrated the range of proper fit for the P-CFTAH and I-CFTAH in congenital heart disease patients. ...
The cutoff values were: BW: 5.71 kg, Ht: 59.0 cm, BSA: 0.31 m(2). These cutoff values were additionally confirmed to be optimal by CT …
Characterization of Favorable Right Ventricular Dimensions for Optimal Reverse Remodeling Following Pulmonary Valve Replacement.
Ghandour HZ, Hammoud MS, Zia A, Rajeswaran J, Najm HK, Pettersson G, Blackstone E, Karamlou T; Members of PVR working group. Ghandour HZ, et al. Semin Thorac Cardiovasc Surg. 2024 Autumn;36(3):345-355. doi: 10.1053/j.semtcvs.2022.11.014. Epub 2023 Feb 24. Semin Thorac Cardiovasc Surg. 2024. PMID: 36841346
RVEDAi decreased slowly over 10 years following PVR. An inflection point at 24 cm(2)/m(2) was noted at 1 year post-PVR and was associated with failure of RV reverse remodeling and RVEDVi 150 mL/m(2). Compared to patients with preoperative RVEDVi 150 mL/m(2) …
RVEDAi decreased slowly over 10 years following PVR. An inflection point at 24 cm(2)/m(2) was noted at 1 year post-PVR and was associ …
Optimizing evaluation in pediatric and young adult patients with Marfan syndrome: Novel longitudinal metrics to track growth of aortic structures.
Bhimani SA, Rahmy A, Kim S, Jin JB, Zahka K, Komarlu R, Svensson LG, Pande A, Karamlou T; Members of Marfan Working Group; Rajeswaran J, Kalahasti V, Desai M, Roselli E, Salim-Hammoud M, Frankel WC, Pettersson G, Blackstone EH, Najm HK, Klein J. Bhimani SA, et al. J Thorac Cardiovasc Surg. 2022 Sep;164(3):724-740.e6. doi: 10.1016/j.jtcvs.2021.12.056. Epub 2022 Mar 16. J Thorac Cardiovasc Surg. 2022. PMID: 35450696 Free article.
Baseline echocardiography data were: CSA/Ht, 3.9 1.4 cm(2)/m; ARd, 2.4 0.89 cm; and ARz, 2.4 1.7. CSA/Ht tracked ARd better compared with ARz (r = 0.91 vs 0.24). ...Surgical repair occurred at CSA/Ht between 5 and 7 cm(2)/m. CONCLUSIONS: CSA/Ht tracked ARd wel …
Baseline echocardiography data were: CSA/Ht, 3.9 1.4 cm(2)/m; ARd, 2.4 0.89 cm; and ARz, 2.4 1.7. CSA/Ht tracked ARd better com …
Thermalization and criticality on an analogue-digital quantum simulator.
Andersen TI, Astrakhantsev N, Karamlou AH, Berndtsson J, Motruk J, Szasz A, Gross JA, Schuckert A, Westerhout T, Zhang Y, Forati E, Rossi D, Kobrin B, Paolo AD, Klots AR, Drozdov I, Kurilovich V, Petukhov A, Ioffe LB, Elben A, Rath A, Vitale V, Vermersch B, Acharya R, Beni LA, Anderson K, Ansmann M, Arute F, Arya K, Asfaw A, Atalaya J, Ballard B, Bardin JC, Bengtsson A, Bilmes A, Bortoli G, Bourassa A, Bovaird J, Brill L, Broughton M, Browne DA, Buchea B, Buckley BB, Buell DA, Burger T, Burkett B, Bushnell N, Cabrera A, Campero J, Chang HS, Chen Z, Chiaro B, Claes J, Cleland AY, Cogan J, Collins R, Conner P, Courtney W, Crook AL, Das S, Debroy DM, Lorenzo L, Barba ADT, Demura S, Donohoe P, Dunsworth A, Earle C, Eickbusch A, Elbag AM, Elzouka M, Erickson C, Faoro L, Fatemi R, Ferreira VS, Burgos LF, Fowler AG, Foxen B, Ganjam S, Gasca R, Giang W, Gidney C, Gilboa D, Giustina M, Gosula R, Dau AG, Graumann D, Greene A, Habegger S, Hamilton MC, Hansen M, Harrigan MP, Harrington SD, Heslin S, Heu P, Hill G, Hoffmann MR, Huang HY, Huang T, Huff A, Huggins WJ, Isakov SV, Jeffrey E, Jiang Z, Jones C, Jordan S, Joshi C, Juhas P, Kafri D, Kang H, Kechedzhi K, Khaire T, Khattar T, Khezri M, … See abstract for full author list ➔ Andersen TI, et al. Nature. 2025 Feb;638(8049):79-85. doi: 10.1038/s41586-024-08460-3. Epub 2025 Feb 5. Nature. 2025. PMID: 39910386 Free PMC article.
Reinforcement learning control of quantum error correction.
Sivak V, Morvan A, Broughton M, Cortiñas RG, Bausch J, Senior AW, Neeley M, Eickbusch A, Shutty N, Beni LA, Spencer JS, Heras FJ, Edlich T, Abanin D, Abbas A, Acharya R, Aigeldinger G, Alcaraz R, Alcaraz S, Andersen TI, Ansmann M, Arute F, Arya K, Askew W, Astrakhantsev N, Atalaya J, Ballard B, Bardin JC, Bates H, Bengtsson A, Karimi MB, Bilmes A, Bilodeau S, Borjans F, Bourassa A, Bovaird J, Bowers D, Brill L, Brooks P, Browne DA, Buchea B, Buckley BB, Burger T, Burkett B, Bushnell N, Busnaina J, Cabrera A, Campero J, Chang HS, Chen S, Chiaro B, Chih LY, Cleland AY, Cochrane B, Cockrell M, Cogan J, Collins R, Conner P, Cook H, Courtney W, Crook AL, Curtin B, Damyanov M, Das S, Debroy DM, Demura S, Donohoe P, Drozdov I, Dunsworth A, Ehimhen V, Elbag AM, Ella L, Elzouka M, Enriquez D, Erickson C, Ferreira VS, Flores M, Burgos LF, Forati E, Ford J, Fowler AG, Foxen B, Fukami M, Fung AWL, Fuste L, Ganjam S, Garcia G, Garrick C, Gasca R, Gehring H, Geiger R, Genois É, Giang W, Gilboa D, Goeders JE, Gonzales EC, Gosula R, de Graaf SJ, Dau AG, Graumann D, Grebel J, Greene A, Gross JA, Guerrero J, Le Guevel L, Ha T, Habegger S, Hadick T, Hadjikhani A, Hamilton MC, Harrigan MP, Harrington… See abstract for full author list ➔ Sivak V, et al. Nature. 2026 Jul 8. doi: 10.1038/s41586-026-10759-2. Online ahead of print. Nature. 2026. PMID: 42420457
Stage 1 and 2 Palliation: Comparing Ductal Stenting and Aorto-Pulmonary Shunts in Single Ventricles with Duct-Dependent Pulmonary Blood Flow.
Ganta S, Haley J, El-Said H, Lane B, Haldeman S, Karamlou T, Moore J, Rao R, Nigro JJ. Ganta S, et al. Pediatr Cardiol. 2024 Mar;45(3):471-482. doi: 10.1007/s00246-023-03386-5. Epub 2024 Jan 24. Pediatr Cardiol. 2024. PMID: 38265483 Free PMC article.
Median Nakata index increase inter-stage was not significant between the PDAS and APS at 94.1 mm(2)/m(2) versus 71.7 mm(2)/m(2) (p = 0.94). Median change in pulmonary artery symmetry (PAS) was - 0.02 and - 0.24, respectively, which was statistically significant (p = …
Median Nakata index increase inter-stage was not significant between the PDAS and APS at 94.1 mm(2)/m(2) versus 71.7 mm(2)/m(2 …
Double Switch in Congenitally Corrected Transposition of the Great Arteries With Incomplete Atrioventricular Septal Defect, Ebsteinoid Tricuspid Valve, Ventricular Outflow Tract Obstructions, and Multiple VSDs.
Najm HK, Tucker D, Patel V, Karamlou T, Oh NA. Najm HK, et al. World J Pediatr Congenit Heart Surg. 2022 Jul;13(4):527-529. doi: 10.1177/21501351221085544. Epub 2022 Mar 11. World J Pediatr Congenit Heart Surg. 2022. PMID: 35275017
We describe the management of a 2 month-old male (BSA 0.27 m(2)) with congenitally corrected transposition of the great arteries (CCTGA), left and right ventricular outflow tract obstruction, incomplete atrioventricular (AV) canal defect, Ebsteinoid left AV valve, and mult …
We describe the management of a 2 month-old male (BSA 0.27 m(2)) with congenitally corrected transposition of the great arteries (CCT …
Early outcomes in patients undergoing transcatheter versus surgical pulmonary valve replacement.
Steinberg ZL, Jones TK, Verrier E, Stout KK, Krieger EV, Karamlou T. Steinberg ZL, et al. Heart. 2017 Sep;103(18):1455-1460. doi: 10.1136/heartjnl-2016-310776. Epub 2017 Mar 28. Heart. 2017. PMID: 28351873
A larger right ventricular end-diastolic dimension (RVEDVI) was the only preoperative variable associated with the primary end point (OR 1.013/10 mL/m(2) increase, p=0.03). Hospital length of stay was significantly longer in patients undergoing SPVR (6.9 1.0 days SPVR vs 1 …
A larger right ventricular end-diastolic dimension (RVEDVI) was the only preoperative variable associated with the primary end point (OR 1.0 …
Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study.
Garcia-Manero G, Abaza Y, Takahashi K, Medeiros BC, Arellano M, Khaled SK, Patnaik M, Odenike O, Sayar H, Tummala M, Patel P, Maness-Harris L, Stuart R, Traer E, Karamlou K, Yacoub A, Ghalie R, Giorgino R, Atallah E. Garcia-Manero G, et al. Blood Adv. 2019 Feb 26;3(4):508-518. doi: 10.1182/bloodadvances.2018027409. Blood Adv. 2019. PMID: 30760466 Free PMC article. Clinical Trial.
Patients received pracinostat 60 mg/d, 3 d/wk, for 3 consecutive weeks, plus azacitidine 75 mg/m(2) daily for 7 days in a 28-day cycle. Primary endpoints were complete remission (CR), CR with incomplete count recovery (CRi), and morphologic leukemia-free state (MLFS) rates …
Patients received pracinostat 60 mg/d, 3 d/wk, for 3 consecutive weeks, plus azacitidine 75 mg/m(2) daily for 7 days in a 28-day cycl …
13 results